Branded Generics Portfolio

About Jamjoom Pharmaceuticals Factory Company

Jamjoom Pharmaceuticals is a key player in the Saudi pharmaceutical market, specializing in the production of high-quality generic medicines and consumer health products. The company has established a strong manufacturing footprint and distribution network, contributing to the Kingdom's healthcare self-sufficiency goals under Vision 2030. Its strategic focus includes expanding its product portfolio through local development and strategic partnerships, while leveraging its market position for regional growth.

About FDC India

FDC Limited is a prominent Indian pharmaceutical player with a legacy dating back to 1936, focusing on developing, manufacturing, and marketing a wide range of pharmaceutical formulations. The company has established a robust commercial footprint in India and over 50 other countries, leveraging its expertise in branded generics and OTC segments. Its strategic direction emphasizes portfolio expansion in chronic therapies, geographical diversification, and strengthening its API vertical to ensure cost competitiveness and supply chain resilience.

About Gulf Pharmaceutical Industries

Gulf Pharmaceutical Industries, known as Julphar, is a publicly listed company on the Abu Dhabi Securities Exchange (ADX) with a mission to provide high-quality, affordable medicines to the MENA region and beyond. The company has established itself through a diversified portfolio spanning diabetes, cardiovascular, gastroenterology, and anti-infective therapeutic areas. Its strategic direction includes expanding its biosimilars pipeline and leveraging its extensive manufacturing and distribution network for regional growth.

Therapeutic Areas

Other Various Therapeutic Areas Drugs